.png)
Advertisement
Advertisement
Trending on Dermatology Times
1
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
2
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
3
Insights from the Multinational RWEAL Study on CHE Etiology, Severity, and Real-World Management
4
NPF Position Statement Aligns Severity Classification With Treatment Needs
5